Work

Prognosis of triple negative breast cancer patients who attain pathological complete response with neoadjuvant carboplatin/docetaxel and do not receive adjuvant anthracycline chemotherapy.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.1015

Authors: Priyanka Sharma, Bruce F. Kimler, Claire Ward, Anne O'Dea, Marc Steven Hoffmann, Jennifer R. Klemp, Marilee McGinness, Jamie Lynn Wagner, Joshua Mammen, Amanda Leigh Amin, Carolyn Lehn, Roy A. Jensen, Andrew K. Godwin, Qamar J. Khan

Institutions: University of Kansas Medical Center, The University of Kansas Cancer Center, University of Kansas

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889964196

Cites:

Cited by: 7

Related to: 10